Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Carcinoma, Medullary × cabozantinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Liver Neoplasms 1 Carcinoma, Medullary 1 Adenoma, Islet Cell 1 Adenocarcinoma, Follicular 1

Interventions

selpercatinib 3 vandetanib 1 pralsetinib 1 cabozantinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04211337 2025-04-20

LIBRETTO-531

Eli Lilly and Company

Phase 3 Active not recruiting

291 enrolled 16 charts 1 FDA

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡